AIM
PRAH

Acrospire Investment Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Acrospire Investment Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-800
Closed -$60K – 1735
2017
Q2 		$60K Sell
800
-600
-43% -$41.6K 0.06% 690
2017
Q1 		$91K Sell
1,400
-2,300
-62% -$135K 0.08% 381
2016
Q4 		$204K Buy
3,700
+1,800
+95% +$98.8K 0.08% 348
2016
Q3 		$107K Sell
1,900
-600
-24% -$29.4K 0.07% 506
2016
Q2 		$104K Buy
2,500
+200
+9% +$9.21K 0.08% 416
2016
Q1 		$98K Buy
+2,300
New +$97.2K 0.07% 335

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Acrospire Investment Management's PRAH Position: Q3 2017 in Review

Acrospire Investment Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2017, closing a stake of 800 shares — an estimated $60K sold.

Acrospire Investment Management first reported a position in PRAH in Q1 2016 and held it in 6 quarters. The position peaked at $204K in Q4 2016. 261 funds tracked by Wall St. Rank hold PRAH as of Q3 2017.

  • Acrospire Investment Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 800 PRA Health Sciences, Inc. shares in Q3 2017, an estimated $60K.
  • Acrospire Investment Management first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's PRA Health Sciences, Inc. position peaked at $204K in Q4 2016.
  • 261 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.